| 标题 |
Improving prevention of moderate to severe dermatologic adverse events in EGFR-mutant advanced NSCLC treated with first-line (1L) subcutaneous (SC) amivantamab + lazertinib: First results from a new COCOON cohort
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | 2026esmo会议 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Sledge
逆旅淹留
hihi
aaaa
why
creat
楠瓜瓜
无极微光
Mic
v0id
null
坚强冰枫
DW
aajhajkahna
古月水兽
xing_xing
Criminology34
乐空思
乘11
夜月残阳
GingerF
wch666
丹丹
叽叽
OK
秋风
皖公网安备34019202002308
